Zheng Cui

1.1k total citations
31 papers, 885 citations indexed

About

Zheng Cui is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Zheng Cui has authored 31 papers receiving a total of 885 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 9 papers in Oncology and 8 papers in Molecular Biology. Recurrent topics in Zheng Cui's work include Liver Disease Diagnosis and Treatment (7 papers), Immune Cell Function and Interaction (7 papers) and Immunotherapy and Immune Responses (6 papers). Zheng Cui is often cited by papers focused on Liver Disease Diagnosis and Treatment (7 papers), Immune Cell Function and Interaction (7 papers) and Immunotherapy and Immune Responses (6 papers). Zheng Cui collaborates with scholars based in United States, Canada and China. Zheng Cui's co-authors include Dennis E. Vance, Christopher J. Walkey, Mark C. Willingham, Amy M. Hicks, Martin Houweling, Luciana Tessitore, Scot J. Stone, Jean E. Vance, Lloyd J. Old and Gregory Riedlinger and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Analytical Biochemistry.

In The Last Decade

Zheng Cui

31 papers receiving 858 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zheng Cui United States 15 350 192 161 132 123 31 885
Ma Carmen Durán-Ruiz Spain 17 583 1.7× 198 1.0× 69 0.4× 142 1.1× 105 0.9× 44 1.1k
Tadao Iwasaki Japan 18 298 0.9× 136 0.7× 90 0.6× 103 0.8× 39 0.3× 31 822
Xiaoming Lu China 19 522 1.5× 94 0.5× 129 0.8× 36 0.3× 80 0.7× 36 917
Nan Lin China 15 443 1.3× 196 1.0× 89 0.6× 112 0.8× 42 0.3× 24 943
Ilaria Buondonno Italy 18 464 1.3× 124 0.6× 181 1.1× 104 0.8× 51 0.4× 23 965
Erol C. Bayraktar United States 8 1.0k 2.9× 61 0.3× 182 1.1× 129 1.0× 33 0.3× 14 1.4k
Donna Conlon United States 19 601 1.7× 75 0.4× 164 1.0× 277 2.1× 149 1.2× 33 1.3k
P. Kölle Germany 9 557 1.6× 72 0.4× 102 0.6× 51 0.4× 35 0.3× 14 925
Suvajit Sen United States 17 354 1.0× 50 0.3× 82 0.5× 55 0.4× 86 0.7× 29 744
Yuyang Liu China 16 520 1.5× 105 0.5× 74 0.5× 86 0.7× 19 0.2× 29 805

Countries citing papers authored by Zheng Cui

Since Specialization
Citations

This map shows the geographic impact of Zheng Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zheng Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zheng Cui more than expected).

Fields of papers citing papers by Zheng Cui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zheng Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zheng Cui. The network helps show where Zheng Cui may publish in the future.

Co-authorship network of co-authors of Zheng Cui

This figure shows the co-authorship network connecting the top 25 collaborators of Zheng Cui. A scholar is included among the top collaborators of Zheng Cui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zheng Cui. Zheng Cui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Qun, Yilei Li, Yanying Wang, et al.. (2016). Quantitative proteomic study of human prostate cancer cells with different metastatic potentials. International Journal of Oncology. 48(4). 1437–1446. 22 indexed citations
2.
Shao, Chengwei, Fang Liu, Wenjun Le, et al.. (2016). In vitro and in vivo targeting imaging of pancreatic cancer using a Fe3O4@SiO2 nanoprobe modified with anti-mesothelin antibody. International Journal of Nanomedicine. 11. 2195–2195. 23 indexed citations
3.
He, Suna, Zheng Cui, Xueqing Wang, et al.. (2015). Cremophor-free intravenous self-microemulsions for teniposide: Safety, antitumor activity in vitro and in vivo. International Journal of Pharmaceutics. 495(1). 144–153. 6 indexed citations
4.
He, Suna, Zheng Cui, Mei Dong, et al.. (2012). A Cremophor-Free Self-Microemulsified Delivery System for Intravenous Injection of Teniposide: Evaluation In Vitro and In Vivo. AAPS PharmSciTech. 13(3). 846–852. 14 indexed citations
5.
Zhang, Jinyang, Bing He, Wei Qu, et al.. (2011). Preparation of the albumin nanoparticle system loaded with both paclitaxel and sorafenib and its evaluationin vitroandin vivo. Journal of Microencapsulation. 28(6). 528–536. 35 indexed citations
6.
Stehle, John, Wei Du, Mark C. Willingham, et al.. (2011). Novel innate cancer killing activity in humans. Cancer Cell International. 11(1). 26–26. 10 indexed citations
7.
8.
Riedlinger, Gregory, et al.. (2010). The spectrum of resistance in SR/CR mice: the critical role of chemoattraction in the cancer/leukocyte interaction. BMC Cancer. 10(1). 179–179. 15 indexed citations
9.
10.
Stehle, John, Mark C. Willingham, Mark C. Willingham, et al.. (2006). Mass spectrometry identification of circulating alpha-1-B glycoprotein, increased in aged female C57BL/6 mice. Biochimica et Biophysica Acta (BBA) - General Subjects. 1770(1). 79–86. 6 indexed citations
11.
Stehle, John, et al.. (2005). A nonterminal method for frequent collection of mouse circulating proteins by peritoneal lavage. Analytical Biochemistry. 349(1). 162–164. 4 indexed citations
12.
Cui, Zheng & Mark C. Willingham. (2004). The effect of aging on cellular immunity against cancer in SR/CR mice. Cancer Immunology Immunotherapy. 53(6). 473–478. 12 indexed citations
13.
Cui, Zheng. (2003). The winding road to the discovery of the SR/CR mice.. PubMed. 3. 14–14. 7 indexed citations
14.
DeLong, Cynthia J., Amy M. Hicks, & Zheng Cui. (2002). Disruption of Choline Methyl Group Donation for Phosphatidylethanolamine Methylation in Hepatocarcinoma Cells. Journal of Biological Chemistry. 277(19). 17217–17225. 28 indexed citations
15.
Tani, Hideaki, et al.. (1998). Pharmacological Properties of Traditional Medicines. XXIV. Classification of Antiasthmatics Based on Constitutional Predispositions.. Biological and Pharmaceutical Bulletin. 21(11). 1169–1173. 5 indexed citations
16.
Stone, Scot J., Zheng Cui, & Jean E. Vance. (1998). Cloning and Expression of Mouse Liver Phosphatidylserine Synthase-1 cDNA. Journal of Biological Chemistry. 273(13). 7293–7302. 54 indexed citations
17.
Cui, Zheng, et al.. (1997). Inverse correlation between expression of phosphatidylethanolamine N-methyltransferase-2 and growth rate of perinatal rat livers. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 1346(1). 10–16. 45 indexed citations
18.
Vance, Dennis E., Christopher J. Walkey, & Zheng Cui. (1997). Phosphatidylethanolamine N-methyltransferase from liver. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 1348(1-2). 142–150. 179 indexed citations
19.
Cui, Zheng & Dennis E. Vance. (1996). Expression of Phosphatidylethanolamine N-Methyltransferase-2 Is Markedly Enhanced in Long Term Choline-deficient Rats. Journal of Biological Chemistry. 271(5). 2839–2843. 64 indexed citations
20.
Houweling, Martin, Zheng Cui, & Dennis E. Vance. (1995). Expression of Phosphatidylethanolamine N-Methyltransferase-2 Cannot Compensate for an Impaired CDP-choline Pathway in Mutant Chinese Hamster Ovary Cells. Journal of Biological Chemistry. 270(27). 16277–16282. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ma Carmen Durán-Ruiz Breakdown of academic impact, for papers by Tadao Iwasaki Breakdown of academic impact, for papers by Xiaoming Lu Breakdown of academic impact, for papers by Nan Lin Breakdown of academic impact, for papers by Ilaria Buondonno Breakdown of academic impact, for papers by Erol C. Bayraktar Breakdown of academic impact, for papers by Donna Conlon Breakdown of academic impact, for papers by P. Kölle Breakdown of academic impact, for papers by Suvajit Sen Breakdown of academic impact, for papers by Yuyang Liu
Rankless by CCL
2026